ID   GL261-Venus-Fluc
AC   CVCL_E9YC
RX   PubMed=33241215;
CC   Characteristics: Transduced with a hPGK-Venus-Fluc-WPRE-mPGK-PuroR construct (PubMed=33241215).
CC   Genetic integration: Method=Transduction; Gene=FPbase; YUJWJ; Venus (Note=Bright yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21938; Mouse glioblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Y003 ! GL261
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
RX   PubMed=33241215; DOI=10.1093/noajnl/vdaa134; PMCID=PMC7680182;
RA   Bozec, Dominique
RA   Sattiraju, Anirudh
RA   Bouras, Alexandros
RA   Jesu Raj, Joe Gerald
RA   Rivera, Daniel
RA   Huang, Yong
RA   Junqueira Alves, Chrystian
RA   Tejero, Rut
RA   Tsankova, Nadejda M.
RA   Zou, Hong-Yan
RA   Hadjipanayis, Constantinos
RA   Friedel, Roland Horst
RT   "Akaluc bioluminescence offers superior sensitivity to track in vivo
RT   glioma expansion.";
RL   Neurooncol. Adv. 2:vdaa134.1-vdaa134.10(2020).
//